Related by context. All words. (Click for frequent words.) 81 Receives Positive Opinion 79 Expanded Indication 78 Meets Primary Endpoint 78 Fast Track Status 77 Mylan Receives Approval 77 Receives Marketing Authorization 76 FDA Accepts 76 Receives Orphan Drug Designation 76 Generic Version 76 Orphan Status 76 Investigational Compound 75 NDA Submission 75 Granted Orphan Drug 74 Submits NDA 74 Phase IIb Trial 74 Osteoporosis Drug 74 Patient Enrollment 74 Phase III Trial 74 Schizophrenia Drug 74 Pivotal Phase III 73 Psoriasis Drug 73 Gout Drug 73 Drug Candidate 73 Phase III Clinical Trial 73 Generic Version Of 73 Improved Survival 73 Prostate Cancer Vaccine 73 Generic Versions 73 Intravenous Formulation 73 ANDA Filing 72 Marketing Authorisation 72 Marketing Authorisation Application 72 Epilepsy Drug 72 Announces Tentative Approval 72 Receives Orphan Drug 72 Improves Survival 72 FDA Approvals 72 Single Dose 72 Sagent Pharmaceuticals Announces 72 Survival Benefit 72 Receives Fast Track 72 Completes Patient Enrollment 72 Study Showed 72 Patients Treated With 72 Arthritis Drug 72 Marketing Authorization 72 Rheumatoid Arthritis Drug 72 Investigational Agent 72 Cholesterol Lowering Drug 72 Anemia Drug 72 Receives Complete Response 72 Complicated Skin 71 Initiates Phase III 71 Severe Sepsis 71 Inhaled Insulin 71 Receives Approvable Letter 71 Myeloma Patients 71 Metastatic Colorectal Cancer 71 Aztreonam Lysine 71 Phase 2a Trial 71 Clinical Trial Results 71 Orphan Designation 71 Million Milestone Payment 71 JAK Inhibitor 71 Lung Cancer Drug 71 Phase IIb Clinical Trial 71 Drug Fails 71 Supplemental Biologics License Application 71 Blood Pressure Drug 71 Migraine Drug 71 Taro Receives 71 Submits Supplemental 71 Milestone Payment 71 Peginterferon alfa 2b 70 Romiplostim 70 PDUFA Date 70 Teva Provides Update 70 Rheumatoid Arthritis Patients 70 Investigational Treatment 70 Files IND 70 Initiate Clinical Trial 70 Adjuvant Treatment 70 Rotavirus Vaccine 70 Phase 2b Clinical Trial 70 Blood Thinner 70 Lambert Eaton Myasthenic 70 Phase III Trials 70 Significantly Improved 70 STELARA TM 70 Grants Orphan Drug 70 Previously Treated 70 FDA Approval 70 Initiate Phase III 70 Chronic Hepatitis B 70 Testosterone Gel 70 Patent Covering 70 Advanced Melanoma 69 Long Term Efficacy 69 Seasonal Influenza Vaccine 69 Colorectal Cancer Patients 69 Orphan Drug Status 69 Prolongs Survival 69 methylnaltrexone bromide 69 Significantly Reduced 69 First Patient Treated 69 Recommends Approval 69 Submits Response 69 Shows Efficacy 69 Glatiramer Acetate 69 Investigational Drug 69 Adjunctive Therapy 69 Completes Enrollment 69 Trobalt 69 ARIXTRA R 69 Demonstrates Positive 69 PRN FDA Approves 69 Demonstrates Significant 69 Paliperidone Palmitate 69 FDA Panel Recommends 69 Pulmonary Arterial Hypertension 69 Recombinant Human 69 Eszopiclone 69 Patients Treated 69 Receives Milestone Payment 69 Low Dose 69 Stronger Warnings 69 Lupus Drug 69 Newly Diagnosed Multiple Myeloma 69 Improves Outcomes 69 HCV Protease Inhibitor 69 SABER ™ 69 Acute Attacks 69 Noxafil 69 Drug Maker 69 Raptiva R 69 Antitumor Activity 69 Study Evaluating 69 Well Tolerated 69 Pafuramidine 69 Clinical Trial Evaluating 69 IND Filing 68 Initiates Enrollment 68 AVASTIN 68 R lenalidomide 68 ONGLYZA TM 68 FDA APPROVES 68 Overactive Bladder 68 Zorbtive TM 68 FDA Clearance 68 Cholesterol Drug 68 Receives Tentative FDA 68 BARACLUDE R 68 Adjuvant Chemotherapy 68 Present Preclinical Data 68 First Patient Enrolled 68 FDA Clears 68 Milestone Payment From 68 Weight Loss Drug 68 Vitrasert R 68 sapropterin dihydrochloride 68 Generic Lovenox 68 Dupuytren Contracture 68 Initiates Clinical Trials 68 Phase 2b Trial 68 Lanthanum Carbonate 68 Pivotal Study 68 Monotherapy 68 SPRYCEL ® 68 FDA Okays 68 Chronic Hepatitis C 68 Submits Biologics License Application 68 Ranolazine 68 Combination Therapy 68 IND Application 68 Pivotal Trial 68 FDA Approves 68 Renal Cell Carcinoma 68 VIVITROL ® 68 BioSante Pharmaceuticals Announces 68 Shingles Vaccine 68 Advanced Prostate Cancer 68 NICE Recommends 68 Hepatitis B Vaccine 68 Febuxostat 68 Generic Protonix 68 Oral Fingolimod 68 Postmenopausal Osteoporosis 68 Orphan Medicinal Product 68 Heartburn Drugs 68 Data Suggest 68 orphan designation 68 Phase 2b Study 68 Sodium Injection 68 Patients Enrolled 67 Release Capsules 67 Esbriet ® 67 Immunosuppressant 67 Combination REOLYSIN R 67 Novel Antibiotic 67 Launches Generic Version 67 Immunomedics Announces 67 Mycophenolate Mofetil 67 Orphan Drug designation 67 Significantly Improves 67 Treatment Experienced 67 alfa 2a 67 Bosutinib 67 Receives Tentative Approval 67 CHMP Opinion 67 Hypertensive Patients 67 Combination Treatment 67 FDA Orphan Drug 67 Orphan Drug status 67 BioElectronics Announces 67 SYCREST 67 Preotact R 67 Improve Survival 67 Oral Calcitonin 67 Bayer Onyx 67 Kuvan R 67 Node Positive 67 Phase 1b Clinical Trial 67 Trial Evaluating 67 Pooled Analysis 67 GTC recombinant human 67 Phase 2a Clinical Trial 67 Extended Release 67 oropharyngeal candidiasis OPC 67 #mg Tablets [002] 67 Resistant Hypertension 67 Is Well Tolerated 67 Treated Patients 67 Soriatane 67 Initiates Phase II 67 Tezampanel 67 Transdermal Patch 67 Multiple Myeloma Patients 67 vapreotide acetate 67 REVLIMID R 67 Levoleucovorin 67 OMP designation 67 Demonstrated Significant 67 SFDA Approval 67 Presents Positive 67 balsalazide disodium Capsules 67 Fondaparinux 67 Initiate Phase 67 Lilly Cymbalta 67 dual endothelin receptor antagonist 67 Fluconazole 67 Pirfenidone 67 Testosterone Patch 67 HER2 Positive Breast Cancer 67 Advanced Colorectal Cancer 67 Kidney Transplant Patients 67 buccal tablets 67 GTC recombinant form 67 Milestone Payments 67 Oral Cladribine 67 Tostrex 66 Statistically Significant 66 Begin Clinical Trials 66 Treating Heart Failure 66 Bazedoxifene 66 Patient Enrolment 66 Pivotal Phase 66 Pegloticase 66 rasagiline tablets 66 Golimumab 66 Unfractionated Heparin 66 Brilique 66 Relapsed Multiple Myeloma 66 Bird Flu Vaccine 66 Keppra ® levetiracetam 66 Pivotal Clinical Trial 66 Amgen Nplate 66 Regulatory Clearance 66 FDA Approvable Letter 66 Telithromycin 66 Tesamorelin 66 Mg Uk 66 Cutaneous T 66 #/#mg 66 Prostate Cancer Patients 66 Significantly Reduces 66 Fungal Infections 66 GRAS Status 66 Budesonide 66 Initiates Clinical 66 Reveals Positive 66 Civacir 66 Initiates Clinical Trial 66 PEGINTRON TM 66 Preclinical Data 66 Dose Escalation 66 Cholesterol Drugs 66 Infected Patients 66 Metformin HCl 66 Orphan Drug Designation 66 REVLIMID ® 66 Maleate 66 Files Investigational 66 abacavir sulfate lamivudine 66 Advanced Renal Cell 66 Treatment Naïve Patients 66 Renal Cancer 66 Phase III Clinical Trials 66 Vaccine Adjuvant 66 Antidepressant Drug 66 Approvable 66 Announcement acc 66 Increlex R 66 Confirms Efficacy 66 Proven Effective 66 Novel Oral 66 Bendamustine 66 Anemia Drugs 66 Treatment Naïve 66 Product Characteristics 66 Hormone Refractory Prostate Cancer 66 Patients Suffering 66 TO AVOID PREGNANCY WHILE 66 Serostim ® 66 Postmenopausal Women 66 Marketing Authorization Application 66 Invasive Fungal Infections 66 Brentuximab Vedotin SGN 66 Methylnaltrexone 66 Renal Impairment 66 Azacitidine 66 Abortion Pill 66 Cellegesic 66 Smallpox Vaccine 66 Breast Cancer Treatment 66 Extended Release Capsules 66 Calcium Acetate 66 Combo Therapy 66 Fludara ® 66 Allergic Rhinitis 66 Inhalation Aerosol 66 First Patient Dosed 66 Afinitor ® 66 Azathioprine 66 Syndrome LEMS 65 Earns Milestone Payment 65 ABILIFY R 65 AstraZeneca Iressa 65 Drug Approvals 65 Epilepsy Drugs 65 Osteoporosis Treatment 65 Application MAA 65 Ciclesonide 65 Irinotecan 65 Demonstrates Potent 65 Tasigna nilotinib 65 Disease Progression 65 Disease Modifying 65 TOPAMAX R 65 Fluticasone 65 levocetirizine 65 Elderly Patients 65 Anti Clotting Drug 65 Treatment Naive Patients 65 Sunesis Pharma 65 Patients Receiving 65 Torisel temsirolimus 65 Presents Preclinical Data 65 HFA MDI 65 refractory chronic lymphocytic 65 Issues Complete Response 65 Relapsing Multiple Sclerosis 65 Pediatric Patients 65 Serious Side Effects 65 Partial Onset Seizures 65 Lung Cancer Patients 65 ORENCIA ® 65 Resubmission 65 Anti Inflammatory Drug 65 PEGylated anti 65 Telzir 65 Desvenlafaxine 65 OSMOPREP TM 65 Statin Drugs 65 Tibotec Therapeutics division 65 Breast Cancer Recurrence 65 Pneumococcal Vaccine 65 R bendamustine hydrochloride 65 Drug Makers 65 Tentative Approval 65 Confirmatory Phase 65 Protease Inhibitor 65 Ambrisentan 65 Known hypersensitivity 65 R Saizen R 65 Mycamine 65 NASDAQ Delisting Notice 65 Nicotine Vaccine 65 NOVARTIS 65 Clinical Study 65 Cervical Cancer Vaccine 65 FIRAZYR 65 Ebola Vaccine 65 Diet Pill 65 Bivalirudin 65 Mimpara 65 Receive Milestone Payment 65 Previously Untreated 65 Factor Xa Inhibitor 65 HCl capsules 65 Patent Broadly Covering 65 Begins Dosing 65 Bevacizumab 65 orphan medicinal product 65 Achieves Primary Endpoint 65 REBETOL combination therapy 65 Drug Coated Stent 65 Successfully Completes Phase 65 Pfizer Revatio 65 Drug Combo 65 Release Tablets 65 solifenacin succinate 65 Neupro R 65 Prophylactic Treatment 65 TNF Blockers 65 Plaque Psoriasis 65 ACE Inhibitors 65 Therapeutic Vaccine 65 Monoclonal Antibody 65 Tigecycline 65 Subgroup Analysis 65 Sensipar R 65 Drug Shows Promise 65 Atypical Antipsychotics 65 C1 Inhibitor 65 Pfizer Sutent 65 Silicone Breast Implants 65 Roche MabThera 65 Atypical Antipsychotic 65 interferon gamma 1b 65 Antipsychotic 65 Dose Ranging Study 65 Camptosar ® 65 Metabolic Disorder 65 UCB Keppra 65 DORIBAX 65 Treatment Reduces 65 Cypher Sirolimus 65 Faropenem 65 Myelodysplastic Syndromes 65 Lung Cancer Survival 65 Vidaza R 65 Benign Prostatic Hyperplasia 65 TEMODAL 65 Vaccine Candidate 65 ATryn ® GTC recombinant 65 Shows Promising 65 Chemotherapy Regimen 65 Zenpep 65 Stem Cell Treatment 65 Etravirine 65 TNF Tumor Necrosis Factor 65 Aloxi ® 65 Sanvar R 65 Darunavir 65 Viagra Soft Cialis Soft 65 PEGylated Fab fragment 65 aripiprazole Abilify 65 Demonstrates Efficacy 65 Phase IIa Trial 65 REPRONEX R menotropins 65 REPRONEX ® menotropins 64 Oracea ® 64 Tipranavir 64 Rotavirus Vaccines 64 Heart Stents 64 Castration Resistant Prostate Cancer 64 Arthritis Drugs 64 Adjuvant Therapy 64 Zidovudine Tablets 64 XAGRID 64 Toremifene 64 induced macular edema 64 Versus Placebo 64 PharmaVitae Profile 64 Efficacious 64 Gonal f R 64 Injection Site 64 Atypical Hemolytic Uremic Syndrome 64 Cancidas 64 Erectile Dysfunction Drug 64 liver resection surgeries 64 Product Designation 64 Serostim R 64 Treat Anemia 64 FOLOTYN ® 64 Commence Phase 64 www.soliris.net 64 Topiramate Tablets 64 Systemic Delivery 64 Topical Gel 64 Initiates Dosing 64 Anti Nausea 64 Diabetic Patients 64 Etanercept 64 Randomized Phase 64 Diabetic Nephropathy 64 Schizophrenia Treatment 64 Posaconazole 64 Cimzia certolizumab pegol 64 Lansoprazole 64 Mesalamine 64 Pazopanib 64 Human Medicinal Products 64 CONBRIZA 64 Filgrastim 64 Voluntary Withdrawal 64 Receives CE Marking 64 nasal calcitonin product 64 Antitrust Clearance 64 Betaferon R 64 Demonstrates Sustained 64 Completes Dosing 64 Interferon Beta 64 sorafenib tablets 64 Wyeth Torisel 64 Darbepoetin Alfa 64 cinacalcet HCl 64 Vaginal Gel 64 Genetically Engineered Salmon 64 Lowers Risk 64 Accelerated Approval 64 Pemetrexed 64 Pivotal Trials 64 Knee Osteoarthritis 64 highly purified pasteurized 64 Study Demonstrates 64 Pain Relievers 64 Ziprasidone 64 Tablet Formulation 64 Nexavar prescribing 64 Relapsed Refractory 64 Phase IIa Clinical Trial 64 Fast Track Designation 64 Yondelis ® 64 Autologous Stem Cell Transplantation 64 Tacrolimus 64 AERIUS 64 FDA Issues Approvable 64 Ixempra 64 Treatment Resistant 64 oral dual endothelin 64 Nebulized 64 Molecular Diagnostic Test 64 VISICOL R 64 Mimpara R 64 TORISEL TM 64 Gets FDA Clearance 64 ONGLYZA ™ 64 Fast Track designations 64 Appears Safe 64 II Clinical Trial 64 Spectrum Pharmaceuticals Announces 64 Soft Tissue Sarcoma 64 GATTEX TM 64 Gaucher Disease 64 Tumor Growth 64 STERIS Corporation Announces 64 Receives Positive 64 Telbivudine 64 Topline Results 64 Gonal f 64 COLAZAL R 64 Dementia Related Psychosis 64 Novartis VIRT X 64 Pegintron 64 adalimumab Humira 64 Oral Interferon 64 Wafer polifeprosan 64 Initiates Phase 64 Antitumor 64 Develop Novel 64 FOR FURTHER INFORMATION ABOUT 64 ® lenalidomide 64 Controlled Trial 64 Anticoagulant 64 Receives FDA Clearance 64 Obtains FDA 64 Million Doses 64 VIVUS Announces 64 Final Approval 64 Lamotrigine 64 Adalimumab 64 Basilea Toctino R 64 Initiates Phase 2b 64 tazobactam 64 Bepreve TM 64 Melphalan 64 rotigotine transdermal patch 64 Anti Tumor Activity 64 BioMarin Pharma 64 Aviptadil 64 Effectively Treats 64 Interferon Alpha 64 Metastatic Melanoma 64 Parnate 64 Eluting Stent 64 Advisers Urge 64 mesylate 64 Granulocyte Colony Stimulating Factor 64 Oral Mucositis 64 Ranexa R 64 Submits Application 64 Heart Failure Patients 64 Pain Medications 64 Asthma Treatment 64 RANK Ligand inhibitor 64 Telaprevir VX 64 COLAZAL ® 64 Venous Thromboembolism 64 Medoxomil 64 Potent Antiviral Activity 64 TRANSDUR ™ 64 Xolegel 64 Tredaptive 64 Expedited Review 64 REBETOL combination 63 Sustained Release 63 NAVISTAR R 63 Angiox ® 63 etanercept Enbrel 63 Influenza Vaccine 63 Pharmacokinetic Study 63 Shows Promise Against 63 Cethromycin 63 Eloxatin ® 63 Levofloxacin 63 Liver Damage 63 Completes Patient Enrolment 63 Velaglucerase Alfa 63 Orapred ODT 63 Tiotropium 63 ALVESCO R 63 POSIDUR ™ 63 Teva Pharma 63 Swine Flu Vaccines 63 Antiviral Drugs 63 Aflibercept 63 Diabetic Neuropathy 63 Certican 63 Advagraf 63 Orally Disintegrating Tablets 63 Efficacy Trial 63 IMiDs ® compound 63 Raptiva ® 63 Bristol Myers Squibb Pravachol 63 Endeavor Drug Eluting 63 Orphan Drug designations 63 Double Blind Placebo 63 Firdapse ™ amifampridine phosphate 63 Aprovel 63 Obtains CE Mark 63 rilonacept 63 acetonide FA 63 ibuprofen Injection 63 Showed Significant 63 Divalproex Sodium 63 DOR BioPharma Announces 63 Copegus ribavirin 63 Sprycel dasatinib 63 Anticancer Drug 63 Orphan designation 63 Cancer Vaccine 63 Sangamo BioSciences Announces 63 Regeneron Pharma 63 memantine HCl 63 Indevus Pharma 63 Investigational Oral 63 Roche Actemra 63 Ecallantide 63 Friedreich Ataxia FRDA 63 SEBIVO 63 Keppra ® XR 63 Epratuzumab 63 Inhalation Solution 63 myelodysplastic myeloproliferative diseases 63 Topical Cream 63 Relapsing Remitting Multiple Sclerosis 63 Oral Contraceptive 63 submitted Marketing Authorization 63 Successfully Treated 63 Gleevec Glivec 63 dasatinib Sprycel ® 63 FUSILEV ® 63 SUTENT ® 63 Vicriviroc 63 PHASE III 63 Diamyd Medical Diamyd 63 Risperidone Oral Solution 63 Captisol enabled 63 Severe Asthma 63 Xcytrin R 63 Cetrorelix 63 Drug Resistant 63 Regenerative Cells 63 CAELYX 63 Treatment Regimen 63 Doripenem 63 atypical Hemolytic Uremic Syndrome 63 Randomized Clinical Trials 63 Oral Solution 63 Lung Cancer Trial 63 Advanced Ovarian Cancer 63 ZALBIN 63 Hematological Malignancies 63 Zeldox 63 Auxilium Pharma 63 Lenalidomide 63 Onyx Pharmaceuticals Announces 63 selective A2A adenosine receptor 63 Sevelamer 63 Adenuric R 63 mg Tablets 63 JOULFERON 63 Kristalose ® lactulose 63 FDA Warns 63 Saizen ® 63 Higher Doses 63 Acne Drug 63 Palonosetron 63 Vioxx Successor 63 Dasatinib 63 ABILIFY ® 63 Gastric Cancer 63 NexMed Receives 63 humanized interleukin 6 63 Fenofibrate 63 Clinical Trial Data 63 Drug Eluting Stent 63 Diabetic Neuropathic Pain 63 Prilosec omeprazole 63 Vandetanib 63 Sumatriptan Succinate 63 Regulatory Approval 63 Itraconazole 63 Icatibant 63 miconazole MBT 63 Nexavar ® 63 Bayer Nexavar 63 sunitinib Sutent 63 Enzyme Replacement Therapy 63 RoACTEMRA 63 Vimpat R 63 Vitrasert ® 63 Drug Eluting Stent System 63 Reduces Risk 63 Acute Heart Failure 63 Luveris 63 Randomized Double Blind 63 Patients Undergoing 63 SUPPRELIN R LA 63 Tocilizumab 63 k Clearance 63 Dose Finding 63 Hematopoietic Stem Cell Transplantation 63 Prospective Randomized 63 Transdermal System 63 Gemzar ® 63 Chronic Sinusitis 63 BioGlue R 63 Companion Diagnostic 63 Fabry Disease 63 Chronic Myeloid Leukemia 63 AstraZeneca Symbicort 63 BUPHENYL 63 Eculizumab 63 Kepivance 63 Anti Tumor 63 alefacept 63 Unsolicited Tender Offer 63 Potential Dangers 63 Thalidomide Pharmion 63 Abstral ® 63 Atomoxetine 63 Paliperidone ER 63 BRILINTA 63 Slow Progression 63 Torisel 63 FASLODEX 63 Clinical Trial Enrollment 63 injection USP 63 Sifrol ® 63 Therapeutic Competitors Companies 63 Nivestim 63 Entecavir 63 Low Doses 63 Randomized Study 63 Ondansetron Injection USP 63 TB Vaccine 63 CAMPATH R 63 Ganciclovir 63 Focetria 63 RNAi Therapeutics 63 duloxetine hydrochloride 63 Teriparatide 63 pralatrexate injection folate analogue 63 Antiplatelet 62 Azilect R 62 Levocetirizine 62 Successfully Treats 62 Safinamide 62 Calcitonin 62 Vfend 62 Cimzia ® certolizumab pegol 62 Preliminary Injunction Against 62 Hycamtin ® 62 OMAPRO ™ 62 sitagliptin metformin 62 Gene Variation 62 HER2 Positive 62 Alvesco ® 62 Gentium Announces 62 nanofiltered plasma derived 62 GABITRIL 62 R adalimumab 62 Viread tenofovir disoproxil fumarate 62 Recurrent Breast Cancer 62 Proves Effective 62 Slows Progression 62 Maribavir 62 Announces FDA Clearance 62 Treating Chronic 62 Sycrest 62 Intelence 62 Acute Ischemic Stroke 62 Reminyl galantamine 62 FDA Approves Generic 62 sodium benzoate prescription 62 Salix Pharma 62 Contaminated Heparin 62 Reduces Mortality 62 Recombinant interferon alpha 62 prescription laxative 62 Anticancer Compound 62 sitaxsentan sodium 62 Biologic License Application 62 Mirapexin 62 oxaliplatin Eloxatin 62 diarrhea fatigue asthenia 62 SAFLUTAN 62 Moxifloxacin 62 Ephedra Ban 62 Enrolls First 62 Chronic Constipation 62 Desvenlafaxine Succinate 62 Decentralized Procedure 62 BENLYSTA ® 62 Smooth Muscle 62 Hospital Acquired Pneumonia 62 NOXAFIL 62 Genetic Tests 62 Immunotherapeutic 62 Biotech Crops 62 Demonstrates Potential 62 Immunosuppression 62 Actimmune ® 62 cetuximab Erbitux R 62 palifermin 62 Patent Ruling 62 Clevudine 62 Therapeutic Potential 62 Osteoarthritis Patients 62 Zegerid OTC 62 Kuvan sapropterin dihydrochloride 62 Authorized Generic 62 Long Term Survival 62 Amlodipine Besylate 62 Liprotamase 62 Pluristem Therapeutics 62 Marketing Authorization Applications 62 investigational pharmacologically unique 62 testosterone buccal system 62 Xyzal ® 62 Nilotinib 62 Unanimously Recommends 62 administered concomitantly 62 Topotecan 62 Romidepsin 62 Keryx Biopharma 62 MOVIPREP R 62 #k Clearance 62 Clinical Efficacy 62 Extended Release Tablets 62 Japanese Encephalitis Vaccine 62 enoxaparin sodium 62 Sustained Efficacy 62 Efficacy Results 62 Obese Patients 62 lexidronam injection 62 pancreatic enzyme replacement 62 pioglitazone hydrochloride 62 ergot derivatives 62 virus HCV protease inhibitor 62 Topical Treatment 62 Aryplase 62 R sorafenib tablets 62 Opterone R 62 Xyrem ® 62 Renvela ® 62 pregabalin Lyrica 62 epoetin zeta 62 Novel Mechanism 62 Sebivo 62 Ramelteon 62 oropharyngeal candidiasis 62 Nexavar sorafenib 62 ferumoxytol Injection 62 nilotinib Tasigna 62 Copegus R 62 Jevtana 62 cUTI 62 Carbidopa Levodopa 62 Kit CD# positive 62 Multaq dronedarone 62 Progressive Multifocal Leukoencephalopathy 62 Patents Covering 62 Abacavir Sulfate 62 Lubiprostone 62 BYETTA ® 62 Panzem R 62 Boceprevir 62 Cold Medicines 62 equine osteoarthritis marketed 62 THALOMID R 62 Vancocin R 62 Aloxi R 62 arthritis PsA 62 XIAFLEX ® 62 Lamivudine 62 Swine Flu Vaccine 62 Announce License Agreement 62 markets Gelclair R 62 Increlex ® 62 Personalized Immunotherapy 62 Cancer Treatments 62 Taxotere ® 62 Renal Function 62 Neoadjuvant 62 submitted Biologics License 62 lamotrigine Lamictal 62 Transcept Pharmaceuticals 62 Resubmits 62 Demonstrates Statistically Significant 62 StaphVAX R 62 Gonal f ® 62 Controlled Study 62 Antifungal 62 Tracleer ® bosentan 62 Sapacitabine 62 Neulasta R 62 transfusional iron overload 62 Rofecoxib 62 topical non steroidal 62 Perindopril 62 Univest Corporation Declares 62 Metastatic Prostate Cancer 62 Exelon rivastigmine 62 Medicinal Products EMEA 62 JAK2 Inhibitor 62 Preclinical Study 62 Malaria Vaccine 62 Aztreonam 62 ISTODAX ® 62 Carboplatin Paclitaxel 62 Didanosine 62 fluvoxamine maleate 62 anti inflammatory NSAID 62 Serdolect ® 62 XIAPEX 62 FDA Complete Response 62 Chronic Lymphocytic Leukemia 62 Onbrez Breezhaler 62 Vaccine Trial 62 ELADUR TM 62 BioDelivery Sciences 62 Presents Preclinical 62 fentanyl buccal tablet 62 SNT-MC#/idebenone 62 Arranon 62 Emtriva Viread 62 Simulect 62 Hormone Therapy 62 Poniard Pharmaceuticals Announces 62 dihydrochloride 62 NEUPOGEN R 62 esomeprazole Nexium 62 MEZAVANT R 62 Liberte TM 62 AMMONUL R sodium phenylacetate 62 FS Antihemophilic Factor Recombinant